Scarborough Advisors »

Clearside Biomedical shares owned by Scarborough Advisors

Quarter-by-quarter ownership of Clearside Biomedical (CLSD) shares owned by Scarborough Advisors from 13F filings

Historical chart of Scarborough Advisors investment in Clearside Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Clearside Biomedical held by Scarborough Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Clearside Biomedical by Scarborough Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $324 277 1.17

More positions owned by Scarborough Advisors

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr Ishs 5 10yr Invt (IGIB)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Msci Emrg Chn (EMXC)
First Tr Exchange Traded Cap Strength Etf (FTCS)
Ishares Tr Eafe Value Etf (EFV)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Scarborough Advisors

Top funds holding Clearside Biomedical

Vanguard Group
Armistice Capital
BlackRock
Geode Capital Management
Renaissance Technologies
Assenagon Asset Management
State Street Corporation
First Manhattan
Morgan Stanley
Bridgeway Capital Management
Rosalind Advisors
Citadel Advisors
Pnc Financial Services
Brown Wealth Management
Northeast Financial Consultants

View all funds holding Clearside Biomedical